Overall Large-Cap Index Performance

The BSE 100 large-cap index has been under pressure recently, registering a decline of 1.12% on 24 Sep 2026. This downward momentum has persisted over the last week, with the index falling 0.41% in the past five days. The advance-decline ratio within the large-cap universe further underscores the bearish tone, with only 19 stocks advancing against 80 decliners, resulting in a weak 0.24x ratio. This imbalance highlights the broad-based selling pressure that has gripped the segment.

Heavyweight Movers: Winners and Laggards

Among the large-cap constituents, ICICI Lombard emerged as the best performer, delivering a robust return of 4.52% on the day. The insurer’s strong showing was a rare bright spot amid the widespread weakness, supported by positive investor sentiment around its growth prospects and resilient underwriting performance. Conversely, PB Fintech was the worst performer, plunging 28.00%, a sharp decline that significantly weighed on the index. The stock’s steep fall reflects concerns over valuation pressures and recent downgrades in market sentiment.

Technical Call Changes and Upgrades

Technical assessments within the large-cap space have seen some notable shifts. Tata Motors has moved from a neutral stance to a bullish technical call, signalling improving momentum in the auto sector. Similarly, GAIL (India) has transitioned from sideways to mildly bullish, suggesting a potential recovery in the energy segment. PB Fintech, despite its recent price weakness, has seen its technical call upgraded from none to bullish, indicating that technical analysts may be anticipating a turnaround. Healthcare stocks such as Apollo Hospitals and Divi’s Laboratories have also seen their technical calls improve from mildly bullish to bullish, reflecting strengthening trends in the defensive healthcare sector.

Defensive Versus Cyclical Trends

The current market environment has accentuated the divergence between defensive and cyclical stocks within the large-cap segment. Defensive sectors such as healthcare and insurance have shown relative resilience, with stocks like ICICI Lombard and Apollo Hospitals outperforming. The upgrade in technical calls for healthcare names like Divi’s Laboratories further supports the defensive bias among investors seeking stability amid broader market volatility.

On the other hand, cyclical sectors continue to face headwinds. The sharp decline in PB Fintech, a financial technology player, exemplifies the challenges faced by growth-oriented cyclical stocks amid tightening valuations and cautious investor sentiment. Tata Motors’ shift to a bullish technical call may signal early signs of recovery in the auto sector, but the overall cyclical space remains under pressure as reflected in the broader index performance.

Rating Changes and Market Outlook

From a fundamental perspective, there have been recent upgrades in stock ratings within the large-cap universe. Notably, PB Fintech has been upgraded from Hold to Buy, signalling renewed confidence in its medium-term prospects despite recent volatility. Similarly, Kotak Mahindra Bank has also seen its rating improved from Hold to Buy, reflecting expectations of steady earnings growth and robust balance sheet metrics.

These rating upgrades suggest that select large-cap stocks may offer attractive entry points for investors willing to navigate near-term volatility. However, the overall market tone remains cautious given the negative breadth and recent index declines.

Investor Takeaways

Investors analysing the large-cap segment should weigh the contrasting trends between defensive and cyclical stocks carefully. Defensive sectors, particularly healthcare and insurance, have demonstrated relative strength and may continue to serve as safe havens amid market uncertainty. The technical upgrades in these sectors reinforce their appeal for risk-averse investors.

Conversely, cyclical stocks remain vulnerable to broader economic and valuation pressures, although selective names like Tata Motors show signs of technical improvement. The recent rating upgrades for PB Fintech and Kotak Mahindra Bank highlight pockets of opportunity, but investors should remain vigilant given the prevailing negative breadth and index weakness.

Overall, the large-cap segment is navigating a challenging environment with mixed signals. A cautious approach that balances exposure between resilient defensive stocks and selectively chosen cyclical names may be prudent in the current market context.

Summary

The large-cap index’s decline of 1.12% on 24 Sep 2026, coupled with a weak advance-decline ratio of 0.24x, reflects broad-based selling pressure. ICICI Lombard’s 4.52% gain contrasts sharply with PB Fintech’s 28.00% fall, illustrating the divergence within the segment. Technical upgrades for Tata Motors, GAIL, Apollo Hospitals, and Divi’s Laboratories suggest pockets of strength, particularly in defensive sectors. Rating upgrades for PB Fintech and Kotak Mahindra Bank provide further nuance to the outlook. Investors should consider these mixed signals carefully when positioning portfolios in the large-cap space.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today